Cost-effectiveness of universal rotavirus vaccination with Rix4414 in Italy;Analisi di costo-efficacia della vaccinazione universale in Italia con il vaccino Rix4414 contro i rotavirus

PharmacoEconomics - Italian Research Articles

Volumn 10, Issue 1, 2008, Pages 23-35

  Standaert, B ^a   Morocco, A ^b   Assael, B ^c   Gabutti, G ^d   Guarino, A ^e   Lopalco, P L ^f   Ruggeri, F M ^g   Titone, L ^h   Tozzi, A ⁱ   Vitali Rosati, G ^j   Zotti, C ^k   Franco, E ^l   Marchetti, Federico ^b  

^a GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^b GSK   (Italy)

^c Centro Regionale Fibrosi Cistica   (Italy)

^d UNIVERSITY OF FERRARA   (Italy)

^e UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^f UNIVERSITY OF BARI   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h UNIVERSITY OF PALERMO   (Italy)

ⁱ BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^j Pediatra di Famiglia   (Italy)

^k UNIVERSITY OF TURIN   (Italy)

^l UNIVERSITY OF ROME TOR VERGATA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DIARRHEA; HEALTH CARE SYSTEM; HOSPITALIZATION; IMMUNIZATION; ITALY; PROBABILITY; SIMULATION; VACCINATION; VIRUS INFECTION;

EID: 40049085399     PISSN: 15909158     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03320638     Document Type: Article

References (47)